SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sigachi Industries - Quaterly Results

30 May 2025 Evaluate
The sales surged to Rs. 1135.40 millions, up 35.72% for the March 2025 quarter as against Rs. 836.55 millions during the corresponding quarter previous year.The Net Profit of the company slipped to Rs. 69.78 millions from Rs. 117.30 millions, a decline of -40.51% on QoQ basis.Operating profit for the quarter ended March 2025 decreased to 204.66 millions as compared to 221.38 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1135.40 836.55 35.72 4078.33 3175.00 28.45 4078.33 3175.00 28.45
Other Income 17.72 71.66 -75.27 200.77 115.73 73.48 200.77 115.73 73.48
PBIDT 204.66 221.38 -7.55 943.39 708.66 33.12 943.39 708.66 33.12
Interest 28.01 24.25 15.51 106.57 70.20 51.81 106.57 70.20 51.81
PBDT 176.65 197.13 -10.39 836.82 638.46 31.07 836.82 638.46 31.07
Depreciation 39.41 27.23 44.73 129.22 87.09 48.38 129.22 87.09 48.38
PBT 137.24 169.90 -19.22 707.60 551.37 28.33 707.60 551.37 28.33
TAX 67.46 52.60 28.25 230.92 141.23 63.51 230.92 141.23 63.51
Deferred Tax 33.30 16.60 100.60 105.18 32.08 227.87 105.18 32.08 227.87
PAT 69.78 117.30 -40.51 476.68 410.14 16.22 476.68 410.14 16.22
Equity 382.12 328.20 16.43 382.12 328.20 16.43 382.12 328.20 16.43
PBIDTM(%) 18.03 26.46 -31.89 23.13 22.32 3.64 23.13 22.32 3.64

Sigachi Industries Share Price

22.52 -0.83 (-3.55%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×